News from calliditas therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

14 Feb, 2020, 06:18 GMT Calliditas Therapeutics - Year-End Report 2019

Recruitment for NefIgArd part A completed on plan and budget "In the last quarter of 2019, we achieved a major milestone: the full recruitment of 200 ...


22 Jan, 2020, 07:13 GMT Positive Opinion Received From EMA Paediatric Committee on the Paediatric Investigation Plan for Nefecon for the Treatment of IgAN

Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the EMA Paediatric Committee (PDCO) has adopted a positive opinion on the...


09 Jan, 2020, 16:44 GMT Calliditas Submits Draft Registration Statement for the Listing of ADSs in the U.S.

Calliditas Therapeutics AB (publ) ("Calliditas" or the "Company") today announces that it has confidentially submitted a draft registration statement ...


23 Dec, 2019, 08:31 GMT The pivotal Phase 3 Clinical Trial NefIgArd Part A Fully Recruited

Calliditas Therapeutics AB (publ) ("Calliditas") today announced the full recruitment of all 200 patients required for Part A of the company's...


19 Dec, 2019, 07:22 GMT Completion of Recruitment of Part A of the Neflgard Pivotal Phase 3 Clinical Trial by Year End

Calliditas Therapeutics AB (publ) ("Calliditas") today announced that 198 out of a total of 200 patients required for Part A of the Company's pivotal ...


17 Dec, 2019, 11:07 GMT China IND Approval Triggers $5 Million Milestone Payment From Everest Medicines

Calliditas Therapeutics AB (publ) ("Calliditas") today announced that a $5 million milestone payment from its partner Everest Medicines II Limited...


14 Nov, 2019, 06:13 GMT Interim Report Q3, 2019

"This third quarter of 2019 saw us move steadily towards full recruitment of the NefIgArd study, despite a somewhat slower pace during the summer...


04 Nov, 2019, 07:21 GMT Calliditas Therapeutics Capital Markets Day Today November 4

Calliditas Therapeutics ("Calliditas") today hosts a Capital Markets Day in Stockholm, moderated by Lars Frick from Börsveckan. The Capital Markets...


01 Oct, 2019, 12:09 BST Save the Date: Calliditas to Host Capital Markets Day in Stockholm on November 4, 2019

Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the company will host a Capital Markets Day in Stockholm on November 4, 2019,...


01 Oct, 2019, 07:16 BST Positive Interactions With EMA Provide Route to Conditional Marketing Authorization of Lead Candidate Nefecon

Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the European Medicines Agency (EMA) has provided positive guidance related to a ...